Viking Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 34.28 -0.59 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.87 | 52 Week High | $5.17 | |||
| Open | $34.63 | 52 Week Low | $0.94 | |||
| Day High | $34.72 | P/E | N/A | |||
| Day Low | $33.60 | EPS | $0.00 | |||
| Volume | 118,039 | |||||
